Pharma rep visits have plunged, and non-personal promotion isn’t making up the gap

We’ve been talking about rep automation and remote communication between reps and physicians for years (live and recorded/on-demand webinars, remote details, chatbots, etc.), because we know that as physicians grow ever-more time crunched and increasingly face employer restrictions on interacting with reps, it’s getting harder for reps to get in to see them.

This year we saw a substantial drop in the share of U.S. physicians who had had in-person meetings with pharma reps – the first in several years – to 54% from 67%, along with a corresponding rise in the number of physicians that had had no interaction with reps, from 24% to 39%.

The number one reason, cited by 43% of physicians, was that they just didn’t have time. Another factor is the self-serve nature of the Internet – 49% of physicians told us that in the past year, they haven’t had a single question that required a pharma rep to answer, because they can find anything they need online.

The drop in in-person rep interaction really isn’t a shocker, but it’s a bit surprising that remote communication (email, phone, remote details) and MSLs aren’t picking up any of the slack. Remote details and other live, on-demand resources can be costly to support, and so are not always offered (12% of physicians report using them, though half would use them more often if more pharmas offered them, and almost half say they’re a valuable supplementary info source between visits). Ditto MSLs (only 28% of physicians have interacted with an MSL in the past 6 months).

However, it’s also true that only 1 in 5 physicians have emailed with reps. This seems like low-hanging fruit for commercial teams. And while it reflects, to some extent, physician preference for face-to-face interaction with reps, we see that physicians who email with reps are far less hidebound in that preference than their in-person-only peers.

This finding suggests that supply of non-personal channels for communication creates demand. Ultimately, we expect to see physicians connecting with pharmas through many touchpoints, including reps and MSLs but also a number of non-personal channels, including self-detailing (which 38% of physicians expect to eventually replace in-person details) and chatbots (30% of physicians are interested in using them to access MSL info).

For now, directing sales forces to check in with their accounts by phone or email seems like the low-hanging fruit. And while communications should always be tailored to the tastes of the individual customer, reps shouldn’t necessarily be afraid to lead this dance – a plurality of physicians either prefer reps initiate emails or want shared initiation.

Our physician research tells us that doctors continue to value the rep relationship -- reps have actually grown more influential with physicians in recent years. They just don’t have time for a traditional cadence of in-person visits anymore. In response, commercial teams will need to learn to utilize pull tactics and multiple touchpoints to keep them informed and engaged.

 

 

Role of advanced IDNs grows as COVID-19 shifts market dynamics

View Now